Beyond Air, Inc. Cash and Restricted Cash
Beyond Air, Inc. (XAIR) had Cash and Restricted Cash of $12.83 million as of 2025-12-31, per its 10-Q filed 2026-02-13.
Financial Statements › Cash Flow › Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-02-13
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $12.83M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $9.86M.
- 2025-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $4.90M.
- 2022-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $82.76M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed |
|---|---|---|
| 2025-12-31 | $12.83M 10-Q · filed 2026-02-13 | |
| 2025-09-30 | $9.86M 10-Q · filed 2025-11-10 | |
| 2025-03-31 | $4.90M 10-Q · filed 2026-02-13 | |
| 2022-06-30 | $82.76M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $90.23M 10-Q · filed 2022-08-11 | |
| 2021-12-31 | $92.71M 10-Q · filed 2022-02-10 | |
| 2021-09-30 | $48.75M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $39.63M 10-Q · filed 2021-08-10 | |
| 2021-03-31 | $35.27M 10-K · filed 2022-06-29 | $35.27M 10-K · filed 2021-06-10 |
| 2020-12-31 | $22.65M 10-Q · filed 2022-02-10 | $22.65M 10-Q · filed 2021-02-09 |
| 2020-09-30 | $22.35M 10-Q · filed 2021-11-12 | $22.35M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $24.45M 10-Q · filed 2021-08-10 | |
| 2020-03-31 | $25.47M 10-K · filed 2021-06-10 | |
| 2019-12-31 | $2.78M 10-Q · filed 2021-02-09 | |
| 2019-09-30 | $2.35M 10-Q · filed 2020-11-12 | |
| 2019-06-30 | $653.02K 10-Q · filed 2020-08-06 | |
| 2019-03-31 | $1.36M 10-K · filed 2020-06-23 | |
| 2018-12-31 | $495.61K 10-Q · filed 2020-02-07 | |
| 2018-09-30 | $333.00K 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $402.00K 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $738.23K 10-K · filed 2019-06-28 | $739.00K 10-KT · filed 2018-06-15 |
| 2017-12-31 | $1.21M 10-K · filed 2019-06-28 | $1.21M 10-KT · filed 2018-06-15 |
| 2017-09-30 | $1.75M 10-Q · filed 2018-11-14 | |
| 2017-06-30 | $5.19M 10-Q · filed 2018-08-14 | |
| 2017-03-31 | $7.14M 10-K · filed 2019-06-28 | $7.14M 10-KT · filed 2018-06-15 |
| 2016-12-31 | $7.20K 10-K · filed 2019-06-28 | $7.00K 10-KT · filed 2018-06-15 |
| 2015-12-31 | $129.00K 10-KT · filed 2018-06-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |